GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT Jayamas Medica Industri Tbk (ISX:OMED) » Definitions » Days Sales Outstanding

PT Jayamas Medica Industri Tbk (ISX:OMED) Days Sales Outstanding : 47.98 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is PT Jayamas Medica Industri Tbk Days Sales Outstanding?

PT Jayamas Medica Industri Tbk's average Accounts Receivable for the three months ended in Mar. 2024 was Rp224,732 Mil. PT Jayamas Medica Industri Tbk's Revenue for the three months ended in Mar. 2024 was Rp427,388 Mil. Hence, PT Jayamas Medica Industri Tbk's Days Sales Outstanding for the three months ended in Mar. 2024 was 47.98.

The historical rank and industry rank for PT Jayamas Medica Industri Tbk's Days Sales Outstanding or its related term are showing as below:

ISX:OMED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.33   Med: 38.71   Max: 48.28
Current: 48.28

During the past 5 years, PT Jayamas Medica Industri Tbk's highest Days Sales Outstanding was 48.28. The lowest was 35.33. And the median was 38.71.

ISX:OMED's Days Sales Outstanding is ranked better than
71.38% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.66 vs ISX:OMED: 48.28

PT Jayamas Medica Industri Tbk's Days Sales Outstanding increased from Mar. 2023 (45.10) to Mar. 2024 (47.98).


PT Jayamas Medica Industri Tbk Days Sales Outstanding Historical Data

The historical data trend for PT Jayamas Medica Industri Tbk's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Jayamas Medica Industri Tbk Days Sales Outstanding Chart

PT Jayamas Medica Industri Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
35.33 38.23 39.41 38.71 41.52

PT Jayamas Medica Industri Tbk Quarterly Data
Dec19 Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.10 50.94 51.55 45.08 47.98

Competitive Comparison of PT Jayamas Medica Industri Tbk's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, PT Jayamas Medica Industri Tbk's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Jayamas Medica Industri Tbk's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Jayamas Medica Industri Tbk's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PT Jayamas Medica Industri Tbk's Days Sales Outstanding falls into.



PT Jayamas Medica Industri Tbk Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PT Jayamas Medica Industri Tbk's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (187045.338 + 208107.666) / 2 ) / 1736989.81*365
=197576.502 / 1736989.81*365
=41.52

PT Jayamas Medica Industri Tbk's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (208107.666 + 241357.093) / 2 ) / 427388.439*365 / 4
=224732.3795 / 427388.439*365 / 4
=47.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Jayamas Medica Industri Tbk  (ISX:OMED) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


PT Jayamas Medica Industri Tbk Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PT Jayamas Medica Industri Tbk's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Jayamas Medica Industri Tbk (ISX:OMED) Business Description

Traded in Other Exchanges
N/A
Address
Sebelah Selatan Jalan By Pass RT 05 / RW 01, Kelurahan Sidomojo, Kecamatan Krian, Sidoarjo, Jawa Timur, East Java, IDN, 61262
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing medical devices and other household health supplies. It initially began with the manufacture of urine bags, OneMed later expanded in the manufacturing business of medical equipment and supplies in Indonesia with a range of variants of products manufactured locally. The Company and its Subsidiaries has three main divisions: Manufacturing; Distribution and Retail.

PT Jayamas Medica Industri Tbk (ISX:OMED) Headlines